世界のパクスロビドAPI市場予測（～2028年）：純度≥99％、純度≥99.5％

• 英文タイトル：Global Paxlovid API Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

• レポートコード：GIR-22E2024 • 出版社/出版日：GlobalInfoResearch / 2022年5月 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（2~3営業日） • 産業分類：化学＆材料

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

パクスロビドAPI市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 GlobalInfoResearchの最新の調査によると、世界のパクスロビドAPIの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 パクスロビドAPI市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメントは次をカバーします。 ・純度≥99％、純度≥99.5％ 用途別セグメントは次のように区分されます。 ・新型コロナウイルス感染症経口薬、研究用試薬、その他 世界のパクスロビドAPI市場の主要な市場プレーヤーは以下のとおりです。 ・Pfizer、Nanjing Hicin Pharmaceutical、Lepu Medical、HAS Biotech、Novasep 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、パクスロビドAPI製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要なパクスロビドAPIメーカーの企業概要、2019年～2022年までのパクスロビドAPIの価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要なパクスロビドAPIメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2017年～2028年までの地域別パクスロビドAPIの販売量、売上、成長性を示しています。 ・第5、6章では、2017年～2028年までのパクスロビドAPIの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのパクスロビドAPI市場予測を収録しています。 ・第12章では、主要な原材料、主要なサプライヤー、およびパクスロビドAPIの産業チェーンを掲載しています。 ・第13、14、15章では、パクスロビドAPIの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 ・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Pfizer、Nanjing Hicin Pharmaceutical、Lepu Medical、HAS Biotech、Novasep ・メーカー別市場シェア ・地域別市場分析2017年-2028年 ・種類別分析2017年-2028年：純度≥99％、純度≥99.5％ ・用途別分析2017年-2028年：新型コロナウイルス感染症経口薬、研究用試薬、その他 ・パクスロビドAPIの北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ ・パクスロビドAPIのヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア ・パクスロビドAPIのアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア ・パクスロビドAPIの南米市場規模2017年-2028年：ブラジル、アルゼンチン ・パクスロビドAPIの中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Paxlovid API market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Paxlovid API market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. COVID-19 Oral Drugs accounting for % of the Paxlovid API global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Purity ≥99% segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Paxlovid API include Pfizer, Nanjing Hicin Pharmaceutical, Lepu Medical, HAS Biotech, and Novasep, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Paxlovid API market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Purity ≥99%
Purity ≥99.5%
Market segment by Application can be divided into
COVID-19 Oral Drugs
Research Reagents
Other
The key market players for global Paxlovid API market are listed below:
Pfizer
Nanjing Hicin Pharmaceutical
Lepu Medical
HAS Biotech
Novasep
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Paxlovid API product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Paxlovid API, with price, sales, revenue and global market share of Paxlovid API from 2019 to 2022.
Chapter 3, the Paxlovid API competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Paxlovid API breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Paxlovid API market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Paxlovid API.
Chapter 13, 14, and 15, to describe Paxlovid API sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 Paxlovid API Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Paxlovid API Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Purity ≥99%
1.2.3 Purity ≥99.5%
1.3 Market Analysis by Application
1.3.1 Overview: Global Paxlovid API Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 COVID-19 Oral Drugs
1.3.3 Research Reagents
1.3.4 Other
1.4 Global Paxlovid API Market Size & Forecast
1.4.1 Global Paxlovid API Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Paxlovid API Sales in Volume (2017-2028)
1.4.3 Global Paxlovid API Price (2017-2028)
1.5 Global Paxlovid API Production Capacity Analysis
1.5.1 Global Paxlovid API Total Production Capacity (2017-2028)
1.5.2 Global Paxlovid API Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Paxlovid API Market Drivers
1.6.2 Paxlovid API Market Restraints
1.6.3 Paxlovid API Trends Analysis
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Paxlovid API Product and Services
2.1.4 Pfizer Paxlovid API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Nanjing Hicin Pharmaceutical
2.2.1 Nanjing Hicin Pharmaceutical Details
2.2.2 Nanjing Hicin Pharmaceutical Major Business
2.2.3 Nanjing Hicin Pharmaceutical Paxlovid API Product and Services
2.2.4 Nanjing Hicin Pharmaceutical Paxlovid API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Lepu Medical
2.3.1 Lepu Medical Details
2.3.2 Lepu Medical Major Business
2.3.3 Lepu Medical Paxlovid API Product and Services
2.3.4 Lepu Medical Paxlovid API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 HAS Biotech
2.4.1 HAS Biotech Details
2.4.2 HAS Biotech Major Business
2.4.3 HAS Biotech Paxlovid API Product and Services
2.4.4 HAS Biotech Paxlovid API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Novasep
2.5.1 Novasep Details
2.5.2 Novasep Major Business
2.5.3 Novasep Paxlovid API Product and Services
2.5.4 Novasep Paxlovid API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Paxlovid API Breakdown Data by Manufacturer
3.1 Global Paxlovid API Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Paxlovid API Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Paxlovid API
3.4 Market Concentration Rate
3.4.1 Top 3 Paxlovid API Manufacturer Market Share in 2021
3.4.2 Top 6 Paxlovid API Manufacturer Market Share in 2021
3.5 Global Paxlovid API Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Paxlovid API Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Paxlovid API Market Size by Region
4.1.1 Global Paxlovid API Sales in Volume by Region (2017-2028)
4.1.2 Global Paxlovid API Revenue by Region (2017-2028)
4.2 North America Paxlovid API Revenue (2017-2028)
4.3 Europe Paxlovid API Revenue (2017-2028)
4.4 Asia-Pacific Paxlovid API Revenue (2017-2028)
4.5 South America Paxlovid API Revenue (2017-2028)
4.6 Middle East and Africa Paxlovid API Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Paxlovid API Sales in Volume by Type (2017-2028)
5.2 Global Paxlovid API Revenue by Type (2017-2028)
5.3 Global Paxlovid API Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Paxlovid API Sales in Volume by Application (2017-2028)
6.2 Global Paxlovid API Revenue by Application (2017-2028)
6.3 Global Paxlovid API Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Paxlovid API Sales by Type (2017-2028)
7.2 North America Paxlovid API Sales by Application (2017-2028)
7.3 North America Paxlovid API Market Size by Country
7.3.1 North America Paxlovid API Sales in Volume by Country (2017-2028)
7.3.2 North America Paxlovid API Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Paxlovid API Sales by Type (2017-2028)
8.2 Europe Paxlovid API Sales by Application (2017-2028)
8.3 Europe Paxlovid API Market Size by Country
8.3.1 Europe Paxlovid API Sales in Volume by Country (2017-2028)
8.3.2 Europe Paxlovid API Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Paxlovid API Sales by Type (2017-2028)
9.2 Asia-Pacific Paxlovid API Sales by Application (2017-2028)
9.3 Asia-Pacific Paxlovid API Market Size by Region
9.3.1 Asia-Pacific Paxlovid API Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Paxlovid API Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Paxlovid API Sales by Type (2017-2028)
10.2 South America Paxlovid API Sales by Application (2017-2028)
10.3 South America Paxlovid API Market Size by Country
10.3.1 South America Paxlovid API Sales in Volume by Country (2017-2028)
10.3.2 South America Paxlovid API Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Paxlovid API Sales by Type (2017-2028)
11.2 Middle East & Africa Paxlovid API Sales by Application (2017-2028)
11.3 Middle East & Africa Paxlovid API Market Size by Country
11.3.1 Middle East & Africa Paxlovid API Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Paxlovid API Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Paxlovid API and Key Manufacturers
12.2 Manufacturing Costs Percentage of Paxlovid API
12.3 Paxlovid API Production Process
12.4 Paxlovid API Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Paxlovid API Typical Distributors
13.3 Paxlovid API Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

---